Barak Zafrir

Prof. Dr. Barak Zafrir

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
YGYaron Goren
Yaron Goren
MKMichal Kushnir
Michal Kushnir
Barak ZafrirBarak Zafrir
Barak Zafrir
STSarit Tabak
Sarit Tabak
BLBasil S. Lewis
Basil S. Lewis
OAOffer Amir
Offer Amir
Aims: Diagnosis and risk stratification of patients with heart failure remain a challenge. The small non-coding RNAs known as microRNAs regulate gene expression and seem to play an important role in the pathogenesis of heart failure. In the current study, we aim to characterize the levels of microRNAs in the sera of chronic systolic heart failure patients vs. controls and assess the possible correlation between elevation in the levels of specific microRNAs and clinical prognostic parameters in heart failure patients. Methods and results: The levels of 186 microRNAs were measured in the sera of 30 stable chronic systolic heart failure patients and 30 controls using quantitative reverse transcription–polymerase chain reaction (qRT–PCR). The differences in microRNA levels between the two groups were characterized, and a score, based on the levels of four specific microRNAs with the most significant increase in the heart failure group (miR-423-5p, miR-320a, miR-22, and miR-92b), was defined. The score was used to discriminate heart failure patients from controls with a sensitivity and specificity of 90%. Moreover, in the heart failure group, there was a significant association between the score and important clinical prognostic parameters such as elevated serum natriuretic peptide levels, a wide QRS, and dilatation of the left ventricle and left atrium (r = 0.63, P = 3e-4; P = 0.009; P = 0.03; and P = 0.01, respectively). Conclusions: Elevated serum levels of specific microRNAs: miR-423-5p, miR-320a, miR-22, and miR-92b, identify systolic heart failure patients and correlate with important clinical prognostic parameters.

15 October 2018 in European Heart Journal
Verified
Journal Article
Closed access
Barak ZafrirBarak Zafrir
Barak Zafrir
LLLars H Lund
Lars H Lund
CLCecile Laroche
Cecile Laroche
FRFrank Ruschitzka
Frank Ruschitzka
MCMaria G Crespo-Leiro
Maria G Crespo-Leiro
EIESC-HFA HF Long-Term Registry Investigators
ESC-HFA HF Long-Term Registry Investigators
To investigate the characteristics long-term prognostic implications (up to ∼2.2 years) of atrial fibrillation (AF) compared to sinus rhythm (SR), between acute and chronic heart failure (HF) with reduced (HFrEF < 40%), mid-range (HFmrEF 40-49%), and preserved (HFpEF ≥ 50%) ejection fraction (EF). Data from the observational, prospective, HF long-term registry of the European Society of Cardiology were analysed. A total of 14 964 HF patients (age 66 ± 13 years, 67% male; 53% HFrEF, 21% HFmrEF, 26% HFpEF) were enrolled. The prevalence of AF was 27% in HFrEF, 29% in HFmrEF, and 39% in HFpEF. Atrial fibrillation was associated with older age, lower functional capacity, and heightened physical signs of HF. Crude rates of mortality and HF hospitalization were higher in patients with AF compared to SR, in each EF subtype. After multivariable adjustment, the hazard ratio of AF for HF hospitalizations was: 1.036 (95% CI 0.888-1.208, P = 0.652) in HFrEF, 1.430 (95% CI 1.087-1.882, P = 0.011) in HFmrEF, and 1.487 (95% CI 1.195-1.851, P < 0.001) in HFpEF; and for combined all-cause death or HF hospitalizations: 0.957 (95% CI 0.843-1.087, P = 0.502), 1.302 (95% CI 1.055-1.608, P = 0.014), and 1.365 (95% CI 1.152-1.619, P < 0.001), respectively. In patients with HFrEF, AF was not associated with worse outcomes in those presenting with either an acute or a chronic presentation of HF. The prevalence of AF increases with increasing EF but its association with worse cardiovascular outcomes, remained significant in patients with HFpEF and HFmrEF, but not in those with HFrEF.

25 January 2013 in Congestive Heart Failure
Verified
Journal Article
Closed access
PDF file
OAOffer Amir
Offer Amir
DRDan Rappaport
Dan Rappaport
Barak ZafrirBarak Zafrir
Barak Zafrir
WAWilliam T. Abraham
William T. Abraham

1 July 2019 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
DHDavid A. Halon
David A. Halon
ILIdit Lavi
Idit Lavi
OBOfra Barnett-Griness
Ofra Barnett-Griness
RRRonen Rubinshtein
Ronen Rubinshtein
Barak ZafrirBarak Zafrir
Barak Zafrir
BLBasil S. Lewis
Basil S. Lewis

1 January 2013 in Respiratory Medicine
Verified
Journal Article
Closed access
Barak ZafrirBarak Zafrir
Barak Zafrir
YAYochai Adir
Yochai Adir
WSWaseem Shehadeh
Waseem Shehadeh
MSMichal Shteinberg
Michal Shteinberg
NSNabia Salman
Nabia Salman
OAOffer Amir
Offer Amir

1 February 2019 in Pancreas
Verified
Journal Article
Closed access
Barak ZafrirBarak Zafrir
Barak Zafrir
WSWalid Saliba
Walid Saliba
AJAyman Jubran
Ayman Jubran
RHRawan Hijazi
Rawan Hijazi
CSChen Shapira
Chen Shapira
Objectives: The diagnosis of severe hypertriglyceridemia (HTG) as a cause for acute pancreatitis is often delayed with limited data on the characteristics and predictors of recurrent pancreatitis in this population. Methods: A regional database of severe HTG level of 1000 mg/dL or greater was analyzed to identify subjects with acute pancreatitis. Factors associated with recurrent pancreatitis during long-term follow-up were investigated. Results: Severe HTG-associated pancreatitis was evident in 171 patients (75% diabetics). Recurrent pancreatitis was observed in 16%; this was associated with younger age, alcohol abuse, and an increase in triglyceride levels. In multivariable analysis, peak triglycerides level of greater than 3000 mg/dL (hazard ratio, 2.92; 95% confidence interval, 1.28–6.64; P = 0.011) and most recent triglycerides level of greater than 500 mg/dL (hazard ratio, 3.72; 95% confidence interval, 1.60–8.66; P = 0.002) remained independently associated with recurrent pancreatitis. These lipid measures as well as alcohol abuse were additionally correlated with a stepwise increase in the number of pancreatitis episodes. Conclusions: Severe HTG-related pancreatitis was closely associated with diabetes. Extreme HTG and a lack of attainment of lower triglyceride levels were independent long-term predictors of recurrent pancreatitis. These findings emphasize the importance of early identification and successful treatment of severe HTG and its underlying disorders to reduce the burden of recurrent pancreatitis.